Skip to main content

Advertisement

Log in

An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Idiopathic intracranial hypertension is a neurological syndrome determined by a rise in intracranial pressure without a detectable cause. Course and prognosis may be changeable, requiring a multidisciplinary approach for its diagnosis and management. Although its precise pathogenesis is still unknown, many studies have been carried out to define the possible causal and associated factors, such as retinoids, steroid hormones, body mass index and recent weight gains, cytokines and adipokines levels. The clinical presentation can be variable including chronic headache, disturbance of vision, diplopia and tinnitus. Even if papilloedema is considered the most specific sign, it could not be observed in more than 5% of patients during the evaluation of the fundus oculi. Neuroradiological signs acquire greater importance in patients who do not present papilloedema and may suggest the diagnosis of idiopathic intracranial hypertension. Other assessments can be useful in the diagnostic process, such as optical coherence tomography, visual evoked potentials, ocular ultrasonography and fundus fluorescein angiography and autofluorescence. Nonetheless, cerebrospinal fluid pressure measurement is required to establish a definite diagnosis. Management may be different, since surgical procedures or lumbar punctures are often required when symptoms develop rapidly leading to a loss of visual function. Apart from these cases, patients can be treated with a pharmacological approach and low-calorie diet, but they also need to be monitored over time since relapses years later are not uncommon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chen J, Wall M (2014) Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 54:1–11. https://doi.org/10.1097/IIO.0b013e3182aabf11

    Article  PubMed  Google Scholar 

  2. Yabe I, Moriwaka F, Notoya A et al (2000) Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol 247:474–475

    Article  CAS  Google Scholar 

  3. Ng M, Fleming T, Robinson M et al (2014) Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet 384:766–781. https://doi.org/10.1016/S0140-6736(14)60460-8

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bruce BB, Kedar S, Van Stavern GP et al (2009) Idiopathic intracranial hypertension in men. Neurology 72:304–309. https://doi.org/10.1212/01.wnl.0000333254.84120.f5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cleves-Bayon C (2018) Idiopathic intracranial hypertension in children and adolescents: an update. Headache 58:485–493. https://doi.org/10.1111/head.13236

    Article  PubMed  Google Scholar 

  6. Daniels AB, Liu GT, Volpe NJ et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (Pseudotumor cerebri). Am J Ophthalmol 143:635–641. https://doi.org/10.1016/j.ajo.2006.12.040

    Article  PubMed  Google Scholar 

  7. Szewka AJ, Bruce BB, Newman NJ, Biousse V (2013) Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 33:4–8. https://doi.org/10.1097/WNO.0b013e31823f852d

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ko MW, Chang SC, Ridha MA et al (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 76:1564–1567. https://doi.org/10.1212/WNL.0b013e3182190f51

    Article  CAS  PubMed  Google Scholar 

  9. Sugerman HJ, DeMaria EJ, Felton WL et al (1997) Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated Pseudotumor cerebri. Neurology 49:507–511

    Article  CAS  Google Scholar 

  10. Kesler A, Kliper E, Shenkerman G, Stern N (2010) Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 117:169–174. https://doi.org/10.1016/j.ophtha.2009.06.030

    Article  PubMed  Google Scholar 

  11. Kesler A, Kliper E, Assayag EB et al (2010) Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis 21:328–333. https://doi.org/10.1097/MBC.0b013e328338ce12

    Article  CAS  PubMed  Google Scholar 

  12. Markey KA, Uldall M, Botfield H et al (2016) Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. J Pain Res 9:223–232. https://doi.org/10.2147/JPR.S80824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Botfield HF, Uldall MS, Westgate CSJ et al (2017) A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan0972

    Article  PubMed  Google Scholar 

  14. ISRCTN - ISRCTN12678718: IIH Pressure—a new treatment for raised brain pressure in Idiopathic Intracranial Hypertension. https://www.isrctn.com/ISRCTN12678718. Accessed 19 Nov 2019

  15. Mitchell JL, Mollan SP, Vijay V, Sinclair AJ (2019) Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension. Curr Opin Neurol 32:422–431. https://doi.org/10.1097/WCO.0000000000000690

    Article  PubMed  PubMed Central  Google Scholar 

  16. Toscano V, Sancesario G, Bianchi P et al (1991) Cerebrospinal fluid estrone in Pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J Endocrinol Invest 14:81–86. https://doi.org/10.1007/BF03350271

    Article  CAS  PubMed  Google Scholar 

  17. Klein A, Stern N, Osher E et al (2013) Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res 38:972–976. https://doi.org/10.3109/02713683.2013.799214

    Article  CAS  PubMed  Google Scholar 

  18. Sinclair AJ, Walker EA, Burdon MA et al (2010) Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab 95:5348–5356. https://doi.org/10.1210/jc.2010-0729

    Article  CAS  PubMed  Google Scholar 

  19. Safety and effectiveness of 11b-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) to treat idiopathic intracranial hypertension.—Full Text View—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02017444. Accessed 19 Nov 2019

  20. Thurtell MJ, Trotti LM, Bixler EO et al (2013) Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol 260:1748–1751. https://doi.org/10.1007/s00415-013-6858-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wall M, Purvin V (2009) Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology 72:300–301. https://doi.org/10.1212/01.wnl.0000336338.97703.fb

    Article  PubMed  Google Scholar 

  22. Onder H, Aksoy M (2019) Resolution of idiopathic intracranial hypertension symptoms by surgery for obstructive sleep apnea in a pediatric patient. J Pediatr Neurosci 14:110–112. https://doi.org/10.4103/jpn.JPN_30_19

    Article  PubMed  PubMed Central  Google Scholar 

  23. Umenishi F, Schrier RW (2002) Induction of human aquaporin-1 gene by retinoic acid in human erythroleukemia HEL cells. Biochem Biophys Res Commun 293:913–917. https://doi.org/10.1016/S0006-291X(02)00316-9

    Article  CAS  PubMed  Google Scholar 

  24. Warner JEA, Larson AJ, Bhosale P et al (2007) Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 27:258–262. https://doi.org/10.1097/WNO.0b013e31815b9af0

    Article  PubMed  Google Scholar 

  25. Tabassi A, Salmasi AH, Jalali M (2005) Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 64:1893–1896. https://doi.org/10.1212/01.WNL.0000163556.31080.98

    Article  CAS  PubMed  Google Scholar 

  26. Jacobson DM, Berg R, Wall M et al (1999) Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 53:1114–1118

    Article  CAS  Google Scholar 

  27. Libien J, Kupersmith MJ, Blaner W et al (2017) Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 372:78–84. https://doi.org/10.1016/j.jns.2016.11.014

    Article  CAS  PubMed  Google Scholar 

  28. Giuseffi V, Wall M, Siegel PZ, Rojas PB (1991) Symptoms and disease associations in idiopathic intracranial hypertension (Pseudotumor cerebri): a case-control study. Neurology 41:239–244

    Article  CAS  Google Scholar 

  29. Wysowski DK, Green L (1995) Serious adverse events in Norplant users reported to the food and drug administration’s MedWatch Spontaneous Reporting System. Obstet Gynecol 85:538–542. https://doi.org/10.1016/0029-7844(94)00457-O

    Article  CAS  PubMed  Google Scholar 

  30. Valenzuela RM, Rai R, Kirk BH et al (2017) An estimation of the risk of Pseudotumor cerebri among users of the Levonorgestrel intrauterine device. Neuroophthalmology 41:192–197. https://doi.org/10.1080/01658107.2017.1304425

    Article  PubMed  PubMed Central  Google Scholar 

  31. Radhakrishnan K, Thacker AK, Bohlaga NH et al (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116:18–28. https://doi.org/10.1016/0022-510x(93)90084-c

    Article  CAS  PubMed  Google Scholar 

  32. Kilgore KP, Lee MS, Leavitt JA et al (2019) A population-based, case-control evaluation of the association between hormonal contraceptives and idiopathic intracranial hypertension. Am J Ophthalmol 197:74–79. https://doi.org/10.1016/j.ajo.2018.09.014

    Article  CAS  PubMed  Google Scholar 

  33. Mollan SP, Davies B, Silver NC et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89:1088–1100. https://doi.org/10.1136/jnnp-2017-317440

    Article  PubMed  Google Scholar 

  34. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in Pseudotumor cerebri of varying etiologies. Neurology 46:198–202

    Article  CAS  Google Scholar 

  35. Hirsch N (2013) Cerebrospinal fluid and its physiology. Anaesth Intensive Care Med 14:379–380. https://doi.org/10.1016/j.mpaic.2013.06.001

    Article  Google Scholar 

  36. Higgins JNP, Gillard JH, Owler BK et al (2004) MR venography in idiopathic intracranial hypertension: unappreciated and misunderstood. J Neurol Neurosurg Psychiatry 75:621–625

    Article  CAS  Google Scholar 

  37. Farb RI, Vanek I, Scott JN et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424. https://doi.org/10.1212/01.wnl.0000066683.34093.e2

    Article  CAS  PubMed  Google Scholar 

  38. Fera F, Bono F, Messina D et al (2005) Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol 252:1021–1025. https://doi.org/10.1007/s00415-005-0710-6

    Article  PubMed  Google Scholar 

  39. Pickard JD, Czosnyka Z, Czosnyka M et al (2008) Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension–a preliminary report. Acta Neurochir Suppl 102:283–285

    Article  CAS  Google Scholar 

  40. Liu X, Di H, Wang J et al (2019) Endovascular stenting for idiopathic intracranial hypertension with venous sinus stenosis. Brain Behav 9:e01279. https://doi.org/10.1002/brb3.1279

    Article  PubMed  PubMed Central  Google Scholar 

  41. Dinkin MJ, Patsalides A (2017) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113–121. https://doi.org/10.1097/WNO.0000000000000426

    Article  PubMed  Google Scholar 

  42. Ahmed RM, Wilkinson M, Parker GD et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 32:1408–1414. https://doi.org/10.3174/ajnr.A2575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. De Simone R, Ranieri A, Sansone M et al (2019) Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci 40:59–70. https://doi.org/10.1007/s10072-019-03775-w

    Article  PubMed  Google Scholar 

  44. Ahmed R, Friedman DI, Halmagyi GM (2011) Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 31:374–380. https://doi.org/10.1097/WNO.0b013e318237eb73

    Article  PubMed  Google Scholar 

  45. De Simone R, Marano E, Fiorillo C et al (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 25:342–344. https://doi.org/10.1007/s10072-004-0368-3

    Article  PubMed  Google Scholar 

  46. Abubaker K, Ali Z, Raza K et al (2011) Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts–case series and literature review. Br J Neurosurg 25:94–99. https://doi.org/10.3109/02688697.2010.544781

    Article  PubMed  Google Scholar 

  47. Iencean SM, Iencean AS (2016) Vascular etiology of intracranial hypertension. Kaohsiung J Med Sci 32:389–390. https://doi.org/10.1016/j.kjms.2016.04.006

    Article  PubMed  Google Scholar 

  48. Türay S, Kabakuş N, Hanci F et al (2019) Cause or consequence: the relationship between cerebral venous thrombosis and idiopathic intracranial hypertension. Neurologist 24:155–160. https://doi.org/10.1097/NRL.0000000000000242

    Article  PubMed  Google Scholar 

  49. de Bezerra MLS, de Ferreira ACAF, de Oliveira-Souza R (2018) Pseudotumor cerebri and glymphatic dysfunction. Front Neurol. https://doi.org/10.3389/fneur.2017.00734

    Article  PubMed  PubMed Central  Google Scholar 

  50. Lenck S, Radovanovic I, Nicholson P et al (2018) Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology 91:515–522. https://doi.org/10.1212/WNL.0000000000006166

    Article  PubMed  Google Scholar 

  51. Benveniste H, Lee H, Volkow ND (2017) The Glymphatic pathway: waste removal from the CNS via cerebrospinal fluid transport. Neuroscientist 23:454–465. https://doi.org/10.1177/1073858417691030

    Article  PubMed  PubMed Central  Google Scholar 

  52. O’Reilly MW, Westgate CS, Hornby C et al (2019) A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. https://doi.org/10.1172/jci.insight.125348

    Article  PubMed  PubMed Central  Google Scholar 

  53. Adderley NJ, Subramanian A, Nirantharakumar K et al (2019) Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.1812

    Article  PubMed  PubMed Central  Google Scholar 

  54. Puustinen T, Tervonen J, Avellan C et al (2019) Psychiatric disorders are a common prognostic marker for worse outcome in patients with idiopathic intracranial hypertension. Clin Neurol Neurosurg 186:105527. https://doi.org/10.1016/j.clineuro.2019.105527

    Article  PubMed  Google Scholar 

  55. Mollan SP, Hoffmann J, Sinclair AJ (2019) Advances in the understanding of headache in idiopathic intracranial hypertension. Curr Opin Neurol 32:92–98. https://doi.org/10.1097/WCO.0000000000000651

    Article  PubMed  Google Scholar 

  56. De Simone R, Ranieri A, Fiorillo C et al (2010) Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci 31:411–415. https://doi.org/10.1007/s10072-010-0229-1

    Article  PubMed  Google Scholar 

  57. May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455–464. https://doi.org/10.1038/nrneurol.2016.93

    Article  CAS  PubMed  Google Scholar 

  58. Chen J, Wall M (2014) Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. https://doi.org/10.1097/IIO.0b013e3182aabf11

    Article  PubMed  PubMed Central  Google Scholar 

  59. Friedman DI, Quiros PA, Subramanian PS et al (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57:1195–1205. https://doi.org/10.1111/head.13153

    Article  PubMed  PubMed Central  Google Scholar 

  60. De Simone R, Ranieri A, Cardillo G, Bonavita V (2011) High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia 31:763–765. https://doi.org/10.1177/0333102411399350

    Article  PubMed  Google Scholar 

  61. Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808. https://doi.org/10.1177/0333102413485658

    Article  Google Scholar 

  62. Curone M, Tullo V, Bussone G (2019) Headache attributed to IIH: clinical evolution in IHS criteria through the years. Neurol Sci 40:55–58. https://doi.org/10.1007/s10072-019-03795-6

    Article  PubMed  Google Scholar 

  63. Wall M, Kupersmith MJ, Kieburtz KD et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701. https://doi.org/10.1001/jamaneurol.2014.133

    Article  PubMed  PubMed Central  Google Scholar 

  64. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160. https://doi.org/10.1111/j.1468-2982.2003.00824.x

    Article  Google Scholar 

  65. Ball AK, Clarke CE (2006) Idiopathic intracranial hypertension. Lancet Neurol 5:433–442. https://doi.org/10.1016/S1474-4422(06)70442-2

    Article  PubMed  Google Scholar 

  66. Mollan SP, Ali F, Hassan-Smith G et al (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87:982–992. https://doi.org/10.1136/jnnp-2015-311302

    Article  PubMed  Google Scholar 

  67. Haywood KL, Mars TS, Potter R et al (2018) Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia 38:1374–1386. https://doi.org/10.1177/0333102417731348

    Article  PubMed  Google Scholar 

  68. Wall M, Subramani A, Chong LX et al (2019) Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 60:1898–1905. https://doi.org/10.1167/iovs.18-26252

    Article  PubMed  Google Scholar 

  69. Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494. https://doi.org/10.1002/ana.410160410

    Article  CAS  PubMed  Google Scholar 

  70. Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the Pseudotumor cerebri syndrome in adults and children. Neurology 81:1159–1165. https://doi.org/10.1212/WNL.0b013e3182a55f17

    Article  PubMed  Google Scholar 

  71. Samancı B, Samancı Y, Şen C et al (2019) Assessment of the olfactory function in patients with idiopathic intracranial hypertension using the Sniffin’ sticks test: a case-control study. Headache 59:848–857. https://doi.org/10.1111/head.13538

    Article  PubMed  Google Scholar 

  72. Zur D, Naftaliev E, Kesler A (2015) Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol 35:26–30. https://doi.org/10.1097/WNO.0000000000000199

    Article  PubMed  Google Scholar 

  73. Campbell WW, DeJong RN (2005) DeJong’s the neurologic examination. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  74. Visa Reñé N, Paredes Carmona F (2019) Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension. Arch Soc Esp Oftalmol. https://doi.org/10.1016/j.oftal.2019.09.006

    Article  PubMed  Google Scholar 

  75. Mollan SP, Markey KA, Benzimra JD et al (2014) A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 14:380–390. https://doi.org/10.1136/practneurol-2014-000821

    Article  PubMed  PubMed Central  Google Scholar 

  76. Digre KB, Nakamoto BK, Warner JEA et al (2009) A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49:185–193. https://doi.org/10.1111/j.1526-4610.2008.01324.x

    Article  PubMed  PubMed Central  Google Scholar 

  77. Manjubashini D, Kiran M, Akshaya S, Nagarajan K (2019) Intrasphenoidal encephalocele with spontaneous cerebrospinal fluid rhinorrhea in idiopathic intracranial hypertension: need for clarity in terminology and imaging delineation. World Neurosurg 132:129–133. https://doi.org/10.1016/j.wneu.2019.08.186

    Article  PubMed  Google Scholar 

  78. Pérez MA, Bialer OY, Bruce BB et al (2013) Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 33:330–337. https://doi.org/10.1097/WNO.0b013e318299c292

    Article  PubMed  PubMed Central  Google Scholar 

  79. Tam EK, Gilbert AL (2019) Spontaneous cerebrospinal fluid leak and idiopathic intracranial hypertension. Curr Opin Ophthalmol 30:467–471. https://doi.org/10.1097/ICU.0000000000000603

    Article  PubMed  Google Scholar 

  80. Maralani PJ, Hassanlou M, Torres C et al (2012) Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 67:656–663. https://doi.org/10.1016/j.crad.2011.12.002

    Article  CAS  PubMed  Google Scholar 

  81. Mallery RM, Rehmani OF, Woo JH et al (2019) Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema. J Neuroophthalmol 39:299–307. https://doi.org/10.1097/WNO.0000000000000767

    Article  PubMed  Google Scholar 

  82. Zetchi A, Labeyrie M-A, Nicolini E et al (2019) Empty sella is a sign of symptomatic lateral sinus stenosis and not intracranial hypertension. AJNR Am J Neuroradiol 40:1695–1700. https://doi.org/10.3174/ajnr.A6210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Auer MK, Stieg MR, Crispin A et al (2018) Primary empty sella syndrome and the prevalence of hormonal dysregulation. Dtsch Arztebl Int 115:99–105. https://doi.org/10.3238/arztebl.2018.0099

    Article  PubMed  Google Scholar 

  84. Kwee RM, Kwee TC (2019) Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. Eur J Radiol 116:106–115. https://doi.org/10.1016/j.ejrad.2019.04.023

    Article  PubMed  Google Scholar 

  85. Agid R, Farb RI, Willinsky RA et al (2006) Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology 48:521–527. https://doi.org/10.1007/s00234-006-0095-y

    Article  CAS  PubMed  Google Scholar 

  86. Delen F, Peker E, Onay M et al (2019) The significance and reliability of imaging findings in Pseudotumor cerebri. Neuroophthalmology 43:81–90. https://doi.org/10.1080/01658107.2018.1493514

    Article  PubMed  Google Scholar 

  87. Wong H, Sanghera K, Neufeld A et al (2019) Clinico-radiological correlation of magnetic resonance imaging findings in patients with idiopathic intracranial hypertension. Neuroradiology. https://doi.org/10.1007/s00234-019-02288-9

    Article  PubMed  Google Scholar 

  88. Rehder D (2019) Idiopathic intracranial hypertension: review of clinical syndrome, imaging findings, and treatment. Curr Probl Diagn Radiol. https://doi.org/10.1067/j.cpradiol.2019.02.012

    Article  PubMed  Google Scholar 

  89. Hu R, Holbrook J, Newman NJ et al (2019) Cerebrospinal fluid pressure reduction results in dynamic changes in optic nerve angle on magnetic resonance imaging. J Neuroophthalmol 39:35–40. https://doi.org/10.1097/WNO.0000000000000643

    Article  PubMed  Google Scholar 

  90. Golden E, Krivochenitser R, Mathews N et al (2019) Contrast-enhanced 3D-FLAIR imaging of the optic nerve and optic nerve head: novel neuroimaging findings of idiopathic intracranial hypertension. AJNR Am J Neuroradiol 40:334–339. https://doi.org/10.3174/ajnr.A5937

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Farrokhi Y, Sharif Kashani S, Aghsaei Fard M et al (2019) Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. Clin Neurol Neurosurg 184:105376. https://doi.org/10.1016/j.clineuro.2019.105376

    Article  PubMed  Google Scholar 

  92. Bono F, Messina D, Giliberto C et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423. https://doi.org/10.1212/01.wnl.0000227892.67354.85

    Article  CAS  PubMed  Google Scholar 

  93. Bono F, Messina D, Giliberto C et al (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255:807–812. https://doi.org/10.1007/s00415-008-0676-2

    Article  CAS  PubMed  Google Scholar 

  94. Bono F, Cristiano D, Mastrandrea C et al (2010) The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers. Cephalalgia 30:145–151. https://doi.org/10.1111/j.1468-2982.2009.01896.x

    Article  CAS  PubMed  Google Scholar 

  95. Ihsclassification 7.1.1 Headache attributed to idiopathic intracranial hypertension (IIH). In: ICHD-3 the international classification of headache disorders 3rd edition. https://www.ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-1-headache-attributed-to-increased-cerebrospinal-fluid-pressure/7-1-1-headache-attributed-to-idiopathic-intracranial-hypertension-iih/. Accessed 15 Apr 2018

  96. Morisaki Y, Nakagawa I, Omoto K et al (2019) Endovascular treatment of idiopathic intracranial hypertension caused by multiple venous sinus stenoses. Surg Neurol Int. https://doi.org/10.25259/SNI-94-2019

    Article  PubMed  PubMed Central  Google Scholar 

  97. Hedjoudje A, Piveteau A, Gonzalez-Campo C et al (2019) The occipital emissary vein: a possible marker for Pseudotumor cerebri. AJNR Am J Neuroradiol 40:973–978. https://doi.org/10.3174/ajnr.A6061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Butros SR, Goncalves LF, Thompson D et al (2012) Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 53:682–688. https://doi.org/10.1258/ar.2012.110705

    Article  PubMed  Google Scholar 

  99. Julayanont P, Karukote A, Ruthirago D et al (2016) Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res 9:87–99. https://doi.org/10.2147/JPR.S60633

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Sarica A, Curcio M, Rapisarda L et al (2019) Periventricular white matter changes in idiopathic intracranial hypertension. Ann Clin Transl Neurol 6:233–242. https://doi.org/10.1002/acn3.685

    Article  PubMed  PubMed Central  Google Scholar 

  101. Batur Caglayan HZ, Ucar M, Hasanreisoglu M et al (2019) Magnetic resonance imaging of idiopathic intracranial hypertension: before and after treatment. J Neuroophthalmol 39:324–329. https://doi.org/10.1097/WNO.0000000000000792

    Article  PubMed  Google Scholar 

  102. Hoffmann J, Mollan SP, Paemeleire K et al (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain 19:93. https://doi.org/10.1186/s10194-018-0919-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Sengupta S, Eckstein C, Collins T (2019) The dilemma of diagnosing idiopathic intracranial hypertension without papilledema in patients with chronic migraine. JAMA Neurol 76:1001–1002. https://doi.org/10.1001/jamaneurol.2019.1696

    Article  PubMed  Google Scholar 

  104. Eide PK, Kerty E (2011) Static and pulsatile intracranial pressure in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:123–128. https://doi.org/10.1016/j.clineuro.2010.10.008

    Article  PubMed  Google Scholar 

  105. Eide PK, Sorteberg W (2008) Changes in intracranial pulse pressure amplitudes after shunt implantation and adjustment of shunt valve opening pressure in normal pressure hydrocephalus. Acta Neurochir (Wien) 150:1141–1147. https://doi.org/10.1007/s00701-008-0138-8

    Article  Google Scholar 

  106. Giliberto C, Mostile G, Lo Fermo S et al (2017) Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis. Neurol Sci 38:2209–2212. https://doi.org/10.1007/s10072-017-3093-4

    Article  PubMed  Google Scholar 

  107. Eide PK, Sorteberg W (2006) Intracranial pressure levels and single wave amplitudes, Glasgow Coma Score and Glasgow Outcome Score after subarachnoid haemorrhage. Acta Neurochir (Wien) 148:1267–1275. https://doi.org/10.1007/s00701-006-0908-0

    Article  CAS  Google Scholar 

  108. Czosnyka M, Pickard JD (2004) Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry 75:813–821

    Article  CAS  Google Scholar 

  109. Czosnyka Z, Czosnyka M (2017) Long-term monitoring of intracranial pressure in normal pressure hydrocephalus and other CSF disorders. Acta Neurochir (Wien) 159:1979–1980. https://doi.org/10.1007/s00701-017-3282-1

    Article  Google Scholar 

  110. Lundberg N (1960) Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 36:1–193

    CAS  PubMed  Google Scholar 

  111. Torbey MT, Geocadin RG, Razumovsky AY et al (2004) Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia 24:495–502. https://doi.org/10.1111/j.1468-2982.2004.00688.x

    Article  CAS  PubMed  Google Scholar 

  112. Bono F, Curcio M, Rapisarda L et al (2018) Cerebrospinal fluid pressure-related features in chronic headache: a prospective study and potential diagnostic implications. Front Neurol 9:1090. https://doi.org/10.3389/fneur.2018.01090

    Article  PubMed  PubMed Central  Google Scholar 

  113. Funnell JP, Craven CL, D’Antona L et al (2018) Intracranial pressure in patients with papilloedema. Acta Neurol Scand 138:137–142. https://doi.org/10.1111/ane.12922

    Article  CAS  PubMed  Google Scholar 

  114. Fleischman D, Kaskar O, Shams R et al (2019) A novel porcine model for the study of cerebrospinal fluid dynamics: development and preliminary results. Front Neurol 10:1137. https://doi.org/10.3389/fneur.2019.01137

    Article  PubMed  PubMed Central  Google Scholar 

  115. Skau M, Yri H, Sander B et al (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574. https://doi.org/10.1007/s00417-012-2039-z

    Article  PubMed  Google Scholar 

  116. Scott CJ, Kardon RH, Lee AG et al (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711. https://doi.org/10.1001/archophthalmol.2010.94

    Article  PubMed  Google Scholar 

  117. Albrecht P, Blasberg C, Ringelstein M et al (2017) Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol 264:1370–1380. https://doi.org/10.1007/s00415-017-8532-x

    Article  PubMed  Google Scholar 

  118. Athappilly G, García-Basterra I, Machado-Miller F et al (2018) Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension. Neuroophthalmology 43:10–17. https://doi.org/10.1080/01658107.2018.1476558

    Article  PubMed  PubMed Central  Google Scholar 

  119. Optical Coherence Tomography Substudy Committee, NORDIC Idiopathic Intracranial Hypertension Study Group (2015) Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology 122:1939–1945.e2. https://doi.org/10.1016/j.ophtha.2015.06.003

    Article  Google Scholar 

  120. Rougier M-B, Le Goff M, Korobelnik J-F (2018) Optical coherence tomography angiography at the acute phase of optic disc edema. Eye Vis (Lond) 5:15. https://doi.org/10.1186/s40662-018-0109-y

    Article  Google Scholar 

  121. Tüntaş Bilen F, Atilla H (2019) Peripapillary vessel density measured by optical coherence tomography angiography in idiopathic intracranial hypertension. J Neuroophthalmol 39:319–323. https://doi.org/10.1097/WNO.0000000000000745

    Article  PubMed  Google Scholar 

  122. Tai TYT (2018) Visual evoked potentials and glaucoma. Asia Pac J Ophthalmol (Phila). https://doi.org/10.22608/APO.2017532

    Article  Google Scholar 

  123. Kesler A, Vakhapova V, Korczyn AD, Drory VE (2009) Visual evoked potentials in idiopathic intracranial hypertension. Clin Neurol Neurosurg 111:433–436. https://doi.org/10.1016/j.clineuro.2008.12.008

    Article  PubMed  Google Scholar 

  124. Hamamci M, Tombul T (2019) Visual evoked potentials follow-up in idiopathic intracranial hypertension. Neurosciences (Riyadh) 24:185–191. https://doi.org/10.17712/nsj.2019.3.20190004

    Article  Google Scholar 

  125. Jeub M, Schlapakow E, Ratz M et al (2019) Sonographic assessment of the optic nerve and the central retinal artery in idiopathic intracranial hypertension. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2019.09.003

    Article  PubMed  Google Scholar 

  126. Rehman H, Khan MS, Nafees M et al (2016) Optic nerve sheath diameter on sonography in idiopathic intracranial hypertension versus normal. J Coll Physicians Surg Pak 26:758–760

    PubMed  Google Scholar 

  127. Messerer M, Berhouma M, Messerer R, Dubourg J (2013) Interest of optic nerve sheath diameter ultrasonography in dectecting non-invasively raised intracranial pressure. Neurochirurgie 59:55–59. https://doi.org/10.1016/j.neuchi.2013.02.001

    Article  CAS  PubMed  Google Scholar 

  128. Dubourg J, Javouhey E, Geeraerts T et al (2011) Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med 37:1059–1068. https://doi.org/10.1007/s00134-011-2224-2

    Article  PubMed  Google Scholar 

  129. Naldi A, Provero P, Vercelli A et al (2019) Optic nerve sheath diameter asymmetry in healthy subjects and patients with intracranial hypertension. Neurol Sci. https://doi.org/10.1007/s10072-019-04076-y

    Article  PubMed  Google Scholar 

  130. Malamos P, Masaoutis P, Georgalas I et al (2015) The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders. Biomed Res Int. https://doi.org/10.1155/2015/247469

    Article  PubMed  PubMed Central  Google Scholar 

  131. Dandy WE (1937) Intracranial pressure without brain tumor. Ann Surg 106:492–513

    Article  CAS  Google Scholar 

  132. Smith JL (1985) Whence Pseudotumor cerebri? J Clin Neuroophthalmol 5:55–56

    CAS  PubMed  Google Scholar 

  133. Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495

    Article  Google Scholar 

  134. Wall M, Corbett JJ (2014) Revised diagnostic criteria for the Pseudotumor cerebri syndrome in adults and children response. Neurology 83:198–200. https://doi.org/10.1212/01.wnl.0000452039.32455.3e

    Article  PubMed  Google Scholar 

  135. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96

    Google Scholar 

  136. Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia 35:553–562. https://doi.org/10.1177/0333102414550109

    Article  PubMed  Google Scholar 

  137. Sinclair AJ, Burdon MA, Nightingale PG et al (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701

    Article  Google Scholar 

  138. Manfield JH, Yu KK-H, Efthimiou E et al (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg 27:513–521. https://doi.org/10.1007/s11695-016-2467-7

    Article  PubMed  Google Scholar 

  139. Merola J, Selezneva L, Perkins R et al (2019) Cerebrospinal fluid diversion versus bariatric surgery in the management of idiopathic intracranial hypertension. Br J Neurosurg. https://doi.org/10.1080/02688697.2019.1698012

    Article  PubMed  Google Scholar 

  140. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP et al (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311:1641–1651. https://doi.org/10.1001/jama.2014.3312

    Article  CAS  Google Scholar 

  141. Ball AK, Howman A, Wheatley K et al (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258:874–881. https://doi.org/10.1007/s00415-010-5861-4

    Article  CAS  PubMed  Google Scholar 

  142. Piper RJ, Kalyvas AV, Young AM et al (2015) Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003434.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  143. ten Hove MW, Friedman DI, Patel AD et al (2016) Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol 36:13–19. https://doi.org/10.1097/WNO.0000000000000322

    Article  PubMed  Google Scholar 

  144. Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327. https://doi.org/10.1111/j.1600-0404.2007.00905.x

    Article  CAS  PubMed  Google Scholar 

  145. Costello F, Skolnik K, Sarna J, Varughese R (2019) Respiratory complications associated with acetazolamide use in the management of idiopathic intracranial hypertension. J Neuroophthalmol. https://doi.org/10.1097/WNO.0000000000000813

    Article  PubMed  Google Scholar 

  146. McCarthy KD, Reed DJ (1974) The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194–201

    CAS  PubMed  Google Scholar 

  147. Panagopoulos GN, Deftereos SN, Tagaris GA, et al (2007) Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci 1

  148. Albuquerque FC, Dashti SR, Hu YC et al (2011) Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg 75:648–652. https://doi.org/10.1016/j.wneu.2010.11.012(discussion 592–595)

    Article  PubMed  Google Scholar 

  149. Alsuhaibani AH, Carter KD, Nerad JA, Lee AG (2011) Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 118:412–414. https://doi.org/10.1016/j.ophtha.2010.06.025

    Article  PubMed  Google Scholar 

  150. Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36:1899–1904. https://doi.org/10.3174/ajnr.A4377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Fonseca PL, Rigamonti D, Miller NR, Subramanian PS (2014) Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol 98:1360–1363. https://doi.org/10.1136/bjophthalmol-2014-304953

    Article  PubMed  Google Scholar 

  152. Sinclair AJ, Kuruvath S, Sen D et al (2011) Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31:1627–1633. https://doi.org/10.1177/0333102411423305

    Article  PubMed  Google Scholar 

  153. Friedman DI (2019) Contemporary management of the Pseudotumor cerebri syndrome. Expert Rev Neurother 19:881–893. https://doi.org/10.1080/14737175.2019.1660163

    Article  CAS  PubMed  Google Scholar 

  154. Surgical Idiopathic Intracranial Hypertension Treatment Trial—full text view - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03501966. Accessed 1 Dec 2019

  155. Teleb MS, Cziep ME, Issa M et al (2015) Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging 25:72–80

    Article  Google Scholar 

  156. Lenck S, Vallée F, Labeyrie M-A et al (2017) Stenting of the lateral sinus in idiopathic intracranial hypertension according to the type of stenosis. Neurosurgery 80:393–400. https://doi.org/10.1227/NEU.0000000000001261

    Article  PubMed  Google Scholar 

  157. Teleb MS, Cziep ME, Lazzaro MA et al (2013) Idiopathic intracranial hypertension. A systematic analysis of transverse sinus stenting. Interv Neurol 2:132–143. https://doi.org/10.1159/000357503

    Article  PubMed  Google Scholar 

  158. Nicholson P, Lenck S, Kucharczyk W, Mendes-Pereira V (2019) Dynamic nature of intracranial venous sinuses in idiopathic intracranial hypertension. Interv Neuroradiol. https://doi.org/10.1177/1591019919871393

    Article  PubMed  PubMed Central  Google Scholar 

  159. Yan F, Rajah G, Ding Y et al (2019) Safety and efficacy of intravascular ultrasound as an adjunct to stenting for cerebral venous sinus stenosis-induced idiopathic intracranial hypertension: a pilot study. J Neurosurg. https://doi.org/10.3171/2018.11.JNS181885

    Article  PubMed  Google Scholar 

  160. Kalyvas AV, Hughes M, Koutsarnakis C et al (2017) Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien) 159:33–49. https://doi.org/10.1007/s00701-016-3010-2

    Article  Google Scholar 

  161. Huna-Baron R, Kupersmith MJ (2002) Idiopathic intracranial hypertension in pregnancy. J Neurol 249:1078–1081. https://doi.org/10.1007/s00415-002-0791-4

    Article  PubMed  Google Scholar 

  162. Kesler A, Kupferminc M (2013) Idiopathic intracranial hypertension and pregnancy. Clin Obstet Gynecol 56:389–396. https://doi.org/10.1097/GRF.0b013e31828f2701

    Article  PubMed  Google Scholar 

  163. Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain. https://doi.org/10.1186/s10194-017-0816-0

    Article  PubMed  PubMed Central  Google Scholar 

  164. Hilely A, Hecht I, Goldenberg-Cohen N, Leiba H (2019) Long-term follow-up of Pseudotumor cerebri syndrome in prepubertal children, adolescents, and adults. Pediatr Neurol. https://doi.org/10.1016/j.pediatrneurol.2019.04.018

    Article  PubMed  Google Scholar 

  165. Afonso CL, Talans A, Monteiro MLR (2015) Factors affecting visual loss and visual recovery in patients with Pseudotumor cerebri syndrome. Arq Bras Oftalmol 78:175–179. https://doi.org/10.5935/0004-2749.20150045

    Article  PubMed  Google Scholar 

  166. Tata G, Kisabay A, Gokcay F, Celebisoy N (2019) Idiopathic intracranial hypertension: are there predictors for visual outcome or recurrences? Clin Neurol Neurosurg 183:105378. https://doi.org/10.1016/j.clineuro.2019.105378

    Article  PubMed  Google Scholar 

  167. Pollak L, Zohar E, Glovinsky Y, Huna-Baron R (2013) Reevaluation of presentation and course of idiopathic intracranial hypertension–a large cohort comprehensive study. Acta Neurol Scand 127:406–412. https://doi.org/10.1111/ane.12060

    Article  CAS  PubMed  Google Scholar 

  168. Onyia CU, Ogunbameru IO, Dada OA et al (2019) Idiopathic intracranial hypertension: Proposal of a stratification strategy for monitoring risk of disease progression. Clin Neurol Neurosurg 179:35–41. https://doi.org/10.1016/j.clineuro.2019.02.013

    Article  PubMed  Google Scholar 

Download references

Funding

This research received no external funding.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, ST, MZ; literature search, ST; resources, ST, SLF, ER, CGC, FP, MZ; writing—original draft preparation, ST; critical revision: SLF, ER, CGC, FP, MZ; writing—review and editing, ST, MZ; visualization, SLF, ER, CGC, FP; supervision, SLF, FP, MZ. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Mario Zappia.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toscano, S., Lo Fermo, S., Reggio, E. et al. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol 268, 3249–3268 (2021). https://doi.org/10.1007/s00415-020-09943-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-020-09943-9

Keywords

Navigation